Arena Pharmaceuticals Inc.
Rank 2
About
Biopharmaceutical company Arena Pharmaceuticals aims to deliver transformational medicines to patients in the US and Switzerland. The company is involved in several preclinical trials with a focus on ulcerative colitis and Crohn’s disease. Arena Pharmaceuticals has a partnership with Everest Medicines to expand into Asian markets.
$99.9900
USD
0.00%
Market cap
$4,982,017,948
Total volume
$10,698
Shares outstanding
49,825,162
Rank 2
About
Biopharmaceutical company Arena Pharmaceuticals aims to deliver transformational medicines to patients in the US and Switzerland. The company is involved in several preclinical trials with a focus on ulcerative colitis and Crohn’s disease. Arena Pharmaceuticals has a partnership with Everest Medicines to expand into Asian markets.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
ARNA |
$10,698
|
100% |
$99.9900
|
Chart